Modest Economic Growth Forecasted For Switzerland In 2026
-
Italiano
it
BAK prevede crescita solo dello 0,9% nel 2026
Original
Read more: BAK prevede crescita solo dello 0,9% nel
العربية
ar
توقّعات بنمو اقتصادي متواضع في سويسرا عام 2026
Read more: توقّعات بنمو اقتصادي متواضع في سويسرا عام
Persistent uncertainty and a weak global investment cycle are likely to dampen the export and capital goods industry, the Basel-based institute indicated on Tuesday.
In concrete terms, as already forecasted in August, the market research institute expects Swiss gross domestic product (GDP) to grow by 0.9% in 2026, excluding sporting events. After an already moderate increase of 1.4% in 2025, Switzerland would experience a further marked slowdown.
The recent declaration of intent in the area of tariffs communicated by the governments of Switzerland and the United States is certainly a welcome relief and in particular reduces the competitive disadvantages of Swiss exporting companies compared to those of comparable foreign countries, says a statement issued today. However, this agreement had already been anticipated in earlier forecasts: without it, the outlook for 2026 would be lower – up to 0.3 percentage points less growth.
US remains unpredictableDespite the expected reduction, tariffs at the border will remain well above the level of early 2025, BAK Economics points out. Moreover, the US government's trade policy remains unpredictable.
The investment commitments made in this context – some Swiss companies plan to make direct investments in the US to the tune of $200 billion (CHF161 billion at current exchange rates) – entail two interrelated economic risks:“If the commitments are not fulfilled, there is a risk of new punitive tariffs being introduced. If, on the other hand, they are implemented to the agreed extent, there is a risk of a shift of investments to the USA” to the detriment of investments in Switzerland.
More More Healthcare innovation US trade deal forces reckoning for Swiss pharma powerhouseThis content was published on Nov 18, 2025 Swiss pharma made massive investment promises to the US that are fueling anxiety about the industry's future in Switzerland.
Read more: US trade deal forces reckoning for Swiss pharma power
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment